The Role of PAF-Acether in Anaphylaxis Demonstrated with the Use of the Antagonist BN 52021
- 1 January 1987
- book chapter
- Published by Springer Nature
- Vol. 21, 97-117
- https://doi.org/10.1007/978-3-0348-7451-9_8
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Desensitization to PAF-induced rat paw oedema by repeated intraplantar injectionsLife Sciences, 1986
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- In vivo inhibition of plasma protein leakage andSalmonella enteritidis—induced mortality in the rat by a specific paf-acether antagonist: BN 52021Inflammation Research, 1986
- Bronchoconstriction by f-met-leu-phe may involve cyclooxygenase and leukotriene-independent mechanismsInternational Journal of Immunopharmacology, 1985
- Lymphocyte sub-populations in patients with allergic and non-allergic asthmaClinical and Experimental Allergy, 1985
- Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pigBiochemical and Biophysical Research Communications, 1985
- Hydrocortisone and ‘macrocortin’ inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytesLife Sciences, 1985
- Activated lung lymphocytes in hypersensitivity pneumonitisJournal of Allergy and Clinical Immunology, 1984
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972